BRIEF published on 04/10/2025 at 19:05, 6 days 2 hours ago TME Pharma strengthens its liquidity contract with Invest Securities Liquidity Contract Oncology INVEST SECURITIES Financial Markets TME Pharma
PRESS RELEASE published on 04/10/2025 at 19:00, 6 days 2 hours ago Inside Information / Other news releases TME Pharma increases resources for liquidity contract with Invest Securities by €5,000 to support cash balance and securities. Details of shares and cash balance provided Liquidity Contract INVEST SECURITIES Clinical-stage Biotechnology Resources TME Pharma
BRIEF published on 02/17/2025 at 08:05, 1 month 27 days ago TME Pharma Outlines 2025 Strategic Roadmap and Initiatives Strategic Partnerships Biotechnology Drug Discovery Cancer Therapy NOX-A12
PRESS RELEASE published on 02/17/2025 at 08:00, 1 month 27 days ago Inside Information / Other news releases TME Pharma CEO Aram Mangasarian outlines key initiatives and milestones for 2025, including strategic partnerships, NOX-A12 clinical development, AI-driven drug discovery, and financial updates Strategic Partnerships Clinical Development CEO Message TME Pharma 2025 Initiatives
BRIEF published on 01/29/2025 at 08:05, 2 months 18 days ago TME Pharma and aimed analytics: Innovative partnership for drug discovery through AI Biotechnology Artificial Intelligence Partnership Cancer Drugs
PRESS RELEASE published on 01/29/2025 at 08:00, 2 months 18 days ago Inside Information / Other news releases TME Pharma collaborates with aimed analytics for AI-driven drug discovery, strengthening capabilities for strategic transactions. The partnership utilizes AI to accelerate drug development and optimize existing therapies Strategic Partnerships Cancer Treatment TME Pharma AI-driven Drug Discovery Aimed Analytics
BRIEF published on 12/23/2024 at 21:09, 3 months 24 days ago Successful public offering of TME Pharma NV Shareholders Capital Increase Cancer Financial Strategies NOX-A12
BRIEF published on 12/04/2024 at 19:55, 4 months 12 days ago TME Pharma Announces Strategic Update and €2.6 Million Financing Plan Public Offer Corporate Strategy Financing Plan NOX-A12 Development Shareholder Priority
PRESS RELEASE published on 12/04/2024 at 19:50, 4 months 12 days ago Inside Information / Other news releases TME Pharma announces corporate strategy update with upcoming €2.6 million financing aimed at further developing therapies for cancer treatment through public offer open to shareholders. CEO Mangasarian highlights strategic goals and plans Financing Cancer Treatment Public Offer Corporate Strategy TME Pharma
BRIEF published on 11/23/2024 at 10:59, 4 months 23 days ago TME Pharma Presents Findings on NOX-A12 in Glioblastoma Cancer Therapy Glioblastoma NOX-A12 Immune Checkpoint Inhibition Tumor Microenvironment
Published on 04/16/2025 at 19:58, 1 hour 31 minutes ago Askeladden Capital Comments on AstroNova Q4 and FY2025 Results
Published on 04/16/2025 at 18:45, 2 hours 44 minutes ago New to The Street Renews Acurx Pharmaceuticals (NASDAQ: ACXP) for Exclusive 6-Month Media Series Including Nationwide TV, Earned Media, and Expanded Digital Reach
Published on 04/16/2025 at 15:45, 5 hours 44 minutes ago Organto Foods Closes Private Placement, Debt Settlement and Amendments to Convertible Notes
Published on 04/16/2025 at 15:15, 6 hours 14 minutes ago urban-gro, Inc. Awarded Three New Contracts with Fogo de Chão
Published on 04/16/2025 at 21:12, 17 minutes ago Annual General Meeting elects Andreas Häberli as new Chairman of the Board of Directors and approves all further proposals
Published on 04/16/2025 at 20:09, 1 hour 20 minutes ago EQS-Adhoc: SBF AG: Preliminary financial figures for 2024
Published on 04/16/2025 at 18:41, 2 hours 48 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 04/16/2025 at 18:10, 3 hours 19 minutes ago Annual general meeting 2025: all proposals of the board of directors approved and Manja Greimeier elected
Published on 04/16/2025 at 19:34, 1 hour 55 minutes ago SFPI GROUP: publication of 2024 annual results
Published on 04/16/2025 at 18:42, 2 hours 47 minutes ago Deezer unveils new features to offer music fans an even more personalized experience
Published on 04/16/2025 at 17:46, 3 hours 43 minutes ago Covivio - Q1 2025 activity: +5.4% revenue growth year-on-year
